LBPO.PS01 · 人群科学 · Late-Breaking

按Lung-RADS分类的CT筛查及随访依从性:一项多中心队列研究

Adherence to CT screening and follow-up by Lung-RADS category: A multicenter cohort study

编号 LB394 展板 24 时间 4/21 02:00–05:00 区域 Section 55 主讲 Pratibha Shrestha, PhD
分会场 Late-Breaking Research: Population Sciences
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Pratibha Shrestha1, Michael K. Gould2, Xiangyang Lou1, Gerard A. Silvestri3, Dejana Braithwaite1, Shama D. Karanth1

1University of Florida, Gainesville, FL,2Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA,3Medical University of South Carolina, Charleston, SC

摘要 Abstract

中文摘要
背景:及时的筛查和随访护理对降低肺癌死亡率至关重要。然而,在真实世界实践中,基线扫描后对低剂量计算机断层扫描(LDCT)或任何CT筛查以及指南推荐随访的依从性仍然较差。本研究的目的是识别在Lung-RADS阴性和阳性各类别中与依从性相关的因素。 方法:我们对55-74岁成人开展了一项回顾性、多中心队列研究,这些成人在2016至2020年间接受了LDCT,在基线前有≥ 1次初级保健就诊,且在既往5年内无肺癌诊断。依从性定义遵循Lung-RADS管理指南。我们拟合了以中心为随机截距的混合效应逻辑回归模型,采用自适应Gauss-Hermite求积法(QPOINTS = 7)进行估计。 结果:在31,795例患者中,排除6279例,剩余21,275例Lung-RADS阴性(1-2)和4,241例Lung-RADS阳性(3-4X)患者。两组的依从性均较低:Lung-RADS 1-2为21.3%,Lung-RADS 3-4X为28.6%。在Lung-RADS 1-2患者中,年龄≥ 65岁者的依从性高于< 65岁者(OR 1.19;95% CI 1.10-1.28),患有COPD者依从性更高(OR 1.15;95% CI 1.06-1.24),但黑人患者的依从性低于白人患者(OR 0.87;95% CI 0.78-0.96),从不吸烟者的依从性低于当前吸烟者(OR 0.65;95% CI 0.53-0.79)。在Lung-RADS 3-4X患者中,COPD仍与依从性呈正相关(OR 1.19;95% CI 1.03-1.39),而与非衰弱状态相比,衰弱前期与较低的依从性相关(OR 0.80;95% CI 0.66-0.98)。大多数其他社会人口统计学和情境因素在校正模型中无统计学意义。 结论:阴性结果后对任何CT筛查的依从性以及阳性发现后对推荐随访的依从性仍然较差。年龄、种族、吸烟行为、COPD和衰弱相关的脆弱性影响依从性模式,凸显了需要有针对性的、以患者为中心的策略,以改善真实世界筛查项目中的留存和随访。 关键词:Lung-RADS、依从性、随访、肺癌
查看英文原文 English abstract
Background: Timely screening and follow-up care are critical for reducing lung cancer mortality. However, adherence to low-dose computed tomography (LDCT) or any CT screening and guideline-recommended follow-up remains poor in real-world practice after the baseline scan. The objective of this study is to identify factors associated with adherence across Lung-RADS negative and positive categories. Methods: We conducted a retrospective, multi-site cohort study of adults aged 55-74 who underwent LDCT between 2016 and 2020, had ≥1 primary care visit before baseline, and had no lung cancer diagnosis in the prior 5 years. Adherence definitions followed Lung-RADS management guidelines. We fit mixed-effects logistic regression models with a random intercept for site, estimated using adaptive Gauss-Hermite quadrature (QPOINTS=7). Results: Of 31,795 patients, 6279 were excluded, leaving 21,275 Lung-RADS negative (1-2) and 4,241 Lung-RADS positive (3-4X) patients. Adherence was low in both groups: 21.3% for Lung-RADS 1-2 and 28.6% for Lung-RADS 3-4X. Among Lung-RADS 1-2 patients, adherence was higher among those aged ≥65 (OR 1.19; 95% CI 1.10-1.28) compared with <65 years, and those with COPD (OR 1.15; 95% CI 1.06-1.24), but lower among Black patients compared with White patients (OR 0.87; 95% CI 0.78-0.96) and never smokers compared with current smokers (OR 0.65; 95% CI 0.53-0.79). Among Lung-RADS 3-4X patients, COPD remained positively associated with adherence (OR 1.19; 95% CI 1.03-1.39), while pre-frailty was associated with lower adherence compared with non-frail status (OR 0.80; 95% CI 0.66-0.98). Most other sociodemographic and contextual factors were not statistically significant in adjusted models. Conclusions: Adherence to any CT screening after negative results and recommended follow-up after positive findings remains poor. Age, race, smoking behavior, COPD, and frailty-related vulnerability contribute to adherence patterns, highlighting the need for targeted, patient-centered strategies to improve retention and follow-up in real-world screening programs. Keywords: Lung-RADS, adherence, follow-up, lung cancer
利益披露 Disclosure
P. Shrestha, None.. M. K. Gould, None.. X. Lou, None.. G. A. Silvestri, None.. D. Braithwaite, None.. S. D. Karanth, None.

← 返回 AACR 2026 检索